Introducing: The Future of Cell Engineering

At EditCo Bio, we're dedicated to making genome engineering easier, faster, and more reliable.

Building Functional, Reliable CRISPR-edited Primary Cells

Streamline your research with edited-to-order primary cells, including our new Knockout CD4+ & CD8+ T-cells.

Learn More

Power Your Research with Knockout iPS Cells

Advance disease modeling, drug discovery, and regenerative medicine with EditCo's high-efficiency, precisely edited iPS cells.

Learn More

Simplified CRISPR: From Design to Delivery

We make it easy for researchers to choose genes and yield and order in just a few clicks. Pick your genes and get started today.

Get Started Now

Services & Products

Explore CRISPR kits and engineered cell services.

Edited Immortalized Cells

Knockout Immortalized Cell Lines

CRISPR knockout cells streamline gene editing, providing ready-to-use cell lines and eliminating months of optimization.

Knock-in Immortalized Cell Lines

Receive precision edits for disease modeling and protein studies, bypassing the complexity of DIY CRISPR.

See Knockout Cells See Knock-in Cells

Edited iPS Cells

Knockout iPS Cell Lines

EditCo's CRISPR Knockout iPS Cells ensure industry-leading editing efficiency in iPS cells, without compromising cell quality. Get reliable gene knockout for critical gene function and disease linkage studies with the assurance of cell integrity.

Knock-in iPS Cell Lines

EditCo's advanced CRISPR knock-in edits in iPS cells unlock breakthrough potential in neuroscience and regenerative medicine. Our efficient automated process for high-quality reproducible iPS cell edits paves the way for your groundbreaking research and therapeutic development.

See Knockout iPS Cell Lines See Knock-in iPS Cell Lines

Edited Primary Cells

Knockout CD8+ T cells

Advance your immunology research with edited-to-order primary CD8+ T cells. Unparalleled editing accuracy and efficiency enable you to bypass the time and resources spent on optimization. EditCo's consistent and functional T cells ensure post-editing experimental reliability and robust downstream results.

Knockout CD4+ T cells

Focus on the main experiments with edited CD4+ T cells. Fast results and guaranteed smart multi-guide design ensure high dependability and cell viability. EditCo’s accurate and reliable T cells deliver functional data while reducing the risk of false negatives in your critical assays.

See Knockout CD+ & CD8+ T cells

CRISPR Kits & Reagents

Gene Knockout Kits

Knockout any human or mouse protein-coding gene with our unique multi-guide RNA strategy. Three spatially coordinated modified SpCas9 sgRNAs induce fragment deletions, obtaining knockout rates greater than 80 percent, and it ships in as few as 5 days—the most reliable knockout strategy, guaranteed.

Arrayed CRISPR sgRNA Libraries

Achieve reliably high knockout efficiencies across your entire CRISPR screen for any human or mouse protein-coding gene. Identifying and validating your targets has never been faster and more reliable, with unparalleled quick delivery starting at 7 days and guaranteed editing efficiency.

Nucleases & Kit Add-ons

EditCo's highly efficient CRISPR kits simplify your science. Complete your CRISPR experiment with SpCas9 nuclease, transfection optimization kits, and add-on controls.

See Gene Knockout Kits See Arrayed CRISPR sgRNA Libraries Nucleases & Add-ons

A lab technician makes microscopic bacteriological examination

Consistent

EditCo is your exclusive hub for research and discovery tools. Enjoy exceptional service, leadership, and infrastructure with a sharp, specialized focus on providing reliable CRISPR Reagents and Engineered Cells quickly and efficiently.

Comprehensive

From Knockout and Knock-in Immortalized Cells to Primary Cells and CRISPR Reagents, EditCo offers a wide range of products to meet diverse research needs. Whatever you edit, we can make it easier to jump-start your research process.

Collaborative

Whether partnering with our development team for custom editing or connecting to our Discovery Partnership Ecosystem for leading cell assays and services, our customers benefit from our commitment to deliver real solutions.

As researchers studying SURF2's role in cancer resistance to chemotherapy, we investigated its depletion in U2OS and HepG2 cell lines. While siRNA yielded initial insights, we sought a more robust approach and partnered with EditCo to generate CRISPR knockout pools. They provided 100% homozygous deletions quickly, allowing us to validate results, isolate clones, and assess SURF2 knockout effects. This work led to our publication in Nature Communications (Tagnères et al.) and continues to drive our research. EditCo’s expertise and efficiency were instrumental, and we look forward to future collaborations.

Simon Lebaron

PhD-HDR, CRCN INSERM. Université de Toulouse (CBI, MCD Unit), France.

EditCo has proven to be an invaluable partner in advancing our—and our client's—research. We highly recommend their services to any organization seeking a reliable, efficient, and skilled collaborator in the field of gene editing.

Alice Roworth

COO, Arctoris

ATCC and EditCo’s strategic partnership brings together the gold standard in authenticated cell lines with EditCo’s leading CRISPR gene-editing tools and services. This powerful alliance allows researchers to harness the highest-quality edited cells, accelerating their research with unparalleled speed, precision, reproducibility, and quality.

Viqar Aslam

Senior Director, Strategic Partnerships, ATCC

We chose EditCo's Arrayed CRISPR Library for our screening project after testing different reagents and finding that the multi-guide RNA design results in superior editing and knockout efficiency. This superior efficiency improves the sensitivity of our screen by enhancing our ability to detect phenotypes—in particular, weak phenotypes—resulting from knockouts.

Marco Jost, Ph.D.

Assistant Professor of Microbiology

At EditCo, our journey began within the pioneering gene-editing landscape of Synthego. We honed our expertise for 5 years, contributing to the gene-editing revolution, and decided to expand into our own company, focusing on quality cell engineering solutions. With our experience as CRISPR leaders, our innovative editing platform, and the highest-quality products, we're here to propel our customers' scientific breakthroughs.

Learn More About Us

Partners

Partners in Innovation

When you partner with EditCo, you harness the transformative power of genome engineering for life science R&D and drive forward human health advancements. Through our Discovery Partners Ecosystem, we offer a unified platform from engineered cells to phenotypic data, streamlining the research process to accelerate drug discovery.

Arctoris

Arctoris is a tech-enabled drug discovery services company that combines wet lab automation and machine learning with a world-class team of experienced researchers to enable the accelerated development of small molecule, biologics, and cell therapy assets.

ATCC

ATCC is a premier global biological materials and information resource and standards organization—and the leading developer and supplier of authenticated cell lines, microorganisms, and associated data for academia, industry, and government.

Azenta

Azenta, a leading provider of life sciences solutions worldwide, provides a full suite of genomic services and reliable cold-chain sample management solutions across areas such as drug development, clinical research, and advanced cell therapies.

BrainXell

BrainXell provides differentiation services to generate high-purity, iPSC-derived human neurons, astrocytes, and microglia for research use with a focus on drug discovery.

Curia

Curia is a global contract research, development, and manufacturing organization (CDMO) offering products and services across the drug development spectrum to help our partners turn ideas into real-world impact.

PhenoVista

PhenoVista specializes in modern human cell-based in vitro assay development and analysis. Recognized for their fully bespoke projects, PhenoVista leverages high-content imaging, enabling life scientists to accelerate their discovery of novel therapeutics and vastly improve human health.

Pluristyx

Pluristyx provides the expertise and tools to support and accelerate the development and commercialization of revolutionary therapeutics to treat serious human diseases by providing unique products, consulting, and contract services, including cell banking and expansion.

0

Gene Pairs IDed in Silico

0

Cell Lines Generated

0+

Novel Drug Targets Validated

Watch the On-Demand Webinar See All Past Webinars

E-Book

Cell Engineering 101 eBook

Discover methods and insights into skillfully generating knockout or knock-in CRISPR edits in a wide-range of cell lines.

Application Note

CRISPR-Engineered Cells Enable Variant Disease Modeling

Understand how all researchers can leverage CRISPR-engineered cells to model multiple genetic variants and clones at scale.

Application Note

Multi-guide RNA Improves CRISPR Efficiency by Generating Fragment Deletions

Learn how intelligently designed multiple gRNAs improve CRISPR knockout efficiency with single exon fragment deletions.

E-book

Unlocking the Genetic Code: The Power of CRISPR in Modern Science

A comprehensive overview of CRISPR technology including its historical development, mechanisms, wide-ranging applications, and potential for changing the future of science.

Explore All Resources